Long-term survival in gliosarcoma with radiation-induced meningeal sarcomas: Case report and molecular features

J Cancer Res Ther. 2015 Jul-Sep;11(3):651. doi: 10.4103/0973-1482.137995.

Abstract

Gliosarcoma is a rare primary malignant tumor of the central nervous system with poor prognosis. The median survival time of this disease ranges from 6 months to 14.8 months. However, a computer literature search indicated few long-term survivors. We investigated a case of a survivor of gliosarcoma with radiation-induced meningeal sarcomas, who showed no indication of recurrence for more than 9 years. A battery of molecular studies was performed to develop a molecular profile of this unique patient. We also reviewed the distinct clinical and molecular features of the tumor.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • DNA Modification Methylases
  • DNA Repair Enzymes
  • Disease-Free Survival
  • Gene Expression Regulation, Neoplastic / radiation effects
  • Gliosarcoma / diagnostic imaging
  • Gliosarcoma / genetics
  • Gliosarcoma / pathology
  • Gliosarcoma / radiotherapy*
  • Humans
  • Isocitrate Dehydrogenase / genetics
  • Magnetic Resonance Imaging
  • Male
  • Meningeal Neoplasms / diagnostic imaging
  • Meningeal Neoplasms / genetics
  • Meningeal Neoplasms / pathology
  • Meningeal Neoplasms / radiotherapy*
  • Neoplasms, Radiation-Induced / genetics
  • Neoplasms, Radiation-Induced / pathology*
  • PTEN Phosphohydrolase / biosynthesis
  • Radiography
  • Treatment Outcome
  • Tumor Suppressor Proteins

Substances

  • Tumor Suppressor Proteins
  • IDH2 protein, human
  • Isocitrate Dehydrogenase
  • IDH1 protein, human
  • DNA Modification Methylases
  • MGMT protein, human
  • PTEN Phosphohydrolase
  • PTEN protein, human
  • DNA Repair Enzymes